- 16.4k views
Anticoagulants in CVD
The financial burden of thrombotic events in cardiovascular disease is enormous. Anticoagulant medication is advised for the treatment and secondary prevention of acute coronary syndrome as well as the prevention of thrombotic events in numerous cardiovascular disorders, such as stroke in atrial fibrillation. Present-day parenteral anticoagulants consist of fondaparinux, low-molecular-weight heparins (LMWHs), and unfractionated heparin. When admitted to the hospital, patients with acute coronary syndrome are typically given either unfractionated heparin or a low-molecular weight heparin (LMWH). Both treatments are equally effective in lowering the risk of death and myocardial infarction, although LMWHs may be safer and don't need to be monitored for blood clotting. Using fondaparinux reduces mortality from acute coronary syndrome considerably when compared to LMWHs or unfractionated heparin. However, long-term outpatient usage of parenteral medications is inconvenient. The only oral anticoagulants available at this time are vitamin K antagonists. A large unmet need exists for new convenient and well-tolerated oral anticoagulants that do not require routine monitoring.
About the Speaker
Dr. Abhishek Tiwari
Consultant Interventional Cardiologist, Ahalia Hospital, Coimbatore
Dr. Abhishek Tiwari, Consultant Interventional Cardiologist, Ahalia Hospital, Coimbatore
Upcoming Case Discussions
Endometriosis- Updates
Endometriosis is a chronic gynecological condition where endometrial-like tissue grows outside the uterus, causing pelvic pain, dysmenorrhea, dyspareunia, and infertility. The ectopic tissue responds to hormonal changes, leading to inflammation, adhesions, and scarring. Diagnosis is based on clinical symptoms, imaging (ultrasound, MRI), and confirmed by laparoscopy with biopsy. Treatment includes NSAIDs, hormonal therapy (OCPs, progestins, GnRH analogs), and surgical excision for severe cases. Fertility treatments like IVF may be needed. While not curable, early diagnosis and management can relieve symptoms and improve quality of life.
Case-Based Approach to Managing GI Malignancies
A Case-Based Approach to managing gastrointestinal (GI) malignancies involves applying a personalized, patient-centered strategy using specific case details to guide treatment decisions. It emphasizes a multidisciplinary team approach, where oncologists, surgeons, pathologists, and radiologists collaborate to determine the best course of action based on tumor type, stage, and patient factors. This method allows for tailored treatment plans, integrating surgery, chemotherapy, radiotherapy, and targeted therapies to optimize outcomes. By discussing individual cases, this approach also aids in identifying potential challenges and refining management protocols to improve patient care.
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Cardiac Rehabilitation
Cardiac rehabilitation is a structured program designed to improve cardiovascular health after heart-related conditions such as heart attacks, heart failure, or surgeries like bypass or stenting. It includes supervised exercise, heart-healthy lifestyle education, nutrition counseling, stress management, and medication guidance. The goal is to enhance heart function, reduce the risk of future heart problems, and improve overall well-being. A multidisciplinary team, including doctors, physiotherapists, and dietitians, tailors the program to each patient’s needs. Regular participation in cardiac rehab lowers mortality rates, prevents hospital readmissions, and promotes long-term cardiovascular health, making it an essential part of heart disease recovery.
Role of Telemedicine in Modern Healthcare
Telemedicine plays a crucial role in modern healthcare by enabling remote consultations, reducing the need for in-person visits, and improving access to medical expertise. It enhances patient care through real-time diagnosis, chronic disease management, and mental health support. By integrating AI and digital health technologies, telemedicine streamlines workflows and optimizes healthcare delivery. It is especially beneficial in rural and underserved areas, bridging gaps in specialist care. As technology advances, telemedicine continues to revolutionize healthcare, making it more efficient, accessible, and patient-centered.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Abhishek Tiwari's Talks on Assimilate
- 12th -Sep-2024, TIME : 5:00PM TO 6:00 PM
- 0
The financial burden of thrombotic events in cardiovascular disease is enormous. Anticoagulant medication is advised for the treatment and secondary prevention of acute coronary syndrome as well as the prevention of thrombotic events in numerous cardiovascular disorders, such as stroke in atrial fibrillation. Present-day parenteral anticoagulants consist of fondaparinux, low-molecular-weight heparins (LMWHs), and unfractionated heparin. When admitted to the hospital, patients with acute coronary syndrome are typically given either unfractionated heparin or a low-molecular weight heparin (LMWH). Both treatments are equally effective in lowering the risk of death and myocardial infarction, although LMWHs may be safer and don't need to be monitored for blood clotting. Using fondaparinux reduces mortality from acute coronary syndrome considerably when compared to LMWHs or unfractionated heparin. However, long-term outpatient usage of parenteral medications is inconvenient. The only oral anticoagulants available at this time are vitamin K antagonists. A large unmet need exists for new convenient and well-tolerated oral anticoagulants that do not require routine monitoring.